Teza Capital Management LLC bought a new position in Ignyta, Inc. (NASDAQ:RXDX) during the fourth quarter, Holdings Channel reports. The fund bought 21,163 shares of the biopharmaceutical company’s stock, valued at approximately $112,000. Teza Capital Management LLC owned approximately 0.05% of Ignyta at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in RXDX. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Ignyta during the third quarter worth approximately $172,000. Dimensional Fund Advisors LP boosted its position in shares of Ignyta by 97.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 57,168 shares of the biopharmaceutical company’s stock worth $303,000 after buying an additional 28,162 shares in the last quarter. Endurant Capital Management LP boosted its position in shares of Ignyta by 158.4% in the third quarter. Endurant Capital Management LP now owns 52,200 shares of the biopharmaceutical company’s stock worth $328,000 after buying an additional 32,000 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Ignyta by 40.2% in the second quarter. Bank of New York Mellon Corp now owns 100,078 shares of the biopharmaceutical company’s stock worth $543,000 after buying an additional 28,681 shares in the last quarter. Finally, Sabby Management LLC boosted its position in shares of Ignyta by 80.0% in the second quarter. Sabby Management LLC now owns 225,000 shares of the biopharmaceutical company’s stock worth $1,220,000 after buying an additional 100,000 shares in the last quarter. 61.93% of the stock is currently owned by institutional investors.
Ignyta, Inc. (NASDAQ:RXDX) traded down 3.927% during midday trading on Friday, reaching $9.175. The company’s stock had a trading volume of 84,121 shares. Ignyta, Inc. has a one year low of $4.15 and a one year high of $9.70. The stock’s 50 day moving average price is $5.83 and its 200-day moving average price is $5.85. The stock’s market cap is $382.16 million.
“Teza Capital Management LLC Buys Shares of 21,163 Ignyta, Inc. (RXDX)” was reported by WKRB News and is the property of of WKRB News. If you are accessing this news story on another domain, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this news story can be viewed at http://www.wkrb13.com/markets/1981534/teza-capital-management-llc-buys-shares-of-21163-ignyta-inc-rxdx.html.
RXDX has been the topic of a number of recent research reports. Jefferies Group LLC reaffirmed a “buy” rating and issued a $20.00 target price on shares of Ignyta in a report on Wednesday, November 30th. Zacks Investment Research raised Ignyta from a “hold” rating to a “buy” rating and set a $6.25 price target on the stock in a report on Friday, November 11th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $16.04.
Ignyta, Inc is an oncology biotechnology company. The Company focuses on an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. Its Rx is focused on discovering, in licensing or acquiring, then developing and commercializing molecularly targeted therapies that, sequentially or in combination, are foundational for eradicating residual disease.
Want to see what other hedge funds are holding RXDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ignyta, Inc. (NASDAQ:RXDX).
This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/1981534/teza-capital-management-llc-buys-shares-of-21163-ignyta-inc-rxdx.html
Receive News & Ratings for Ignyta Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ignyta Inc. and related companies with MarketBeat.com's FREE daily email newsletter.